Not medical advice. This website is not medical advice, a diagnosis, a match to a trial, or a recommendation to join a study. Listings are plain-English rewrites of public ClinicalTrials.gov records. Whether a site is still enrolling, and whether you qualify, can only be confirmed by the study team and your clinician. Source registry: ClinicalTrials.gov. Editorial rules: methodology.
RecruitingNot a traditional drug phaseobservationalRules rewrite
Not a traditional drug phase: Physiotherapist assessment for Obstructive Sleep Disordered Breathing
This study investigates the hypothesis that, in children, tongue motor functions can predict both the anatomical site and the degree of upper airway obstruction contributing to obstructive sleep-disordered breathing.
This is an observational study. You are not assigned a new experimental drug. Researchers measure what already happens in your care or in daily life.
Phase labels are FDA/ICH categories applied to the registry Phase field. They are not a finding that this study succeeded.
What the registry says happens
This listing is observational (StudyType). The registry does not assign a new experimental drug as the study intervention.
They plan to enroll about 48 people at Brussels. Taking part typically means study visits and measurements plus check-ins.
Official title (unrewritten)
Tongue Motor Functions Assessment as a Screening Tool for Obstructive Sleep Disordered Breathing in Children
Interventions: Physiotherapist assessment, ENT assessment, Drug-Induced Sleep Endoscopy
Primary outcome (registry wording): Extent of tongue base obstruction
Who it is for (from inclusion criteria)
Ages 4 Years to 17 Years
Age between 4 and 17 years old
Medical diagnosis of obstructive sleep-disordered breathing requiring surgical removal of tonsils (partial or total) and/or adenoids, excluding type III (e.g., linked to a neurological comorbidity)
Positive Pediatric Sleep Questionnaire (8 or more positive responses)
Eligibility for surgical intervention
Who the registry excludes
Previous surgery of the upper airway or oral cavity
History of or current head or neck cancer
Cranial, upper airway, or oral cavity malformation
Background: Obstructive sleep apnea (OSA) occurs when the blockage of the airway causes a person to stop breathing involuntarily for 10 seconds or more throughout the night during sleep. Pediatric OSA can be especially concerning and can have long-term effects.
Substance use disorder (SUD) and posttraumatic stress disorder (PTSD) frequently co-occur and having both disorders is associated with greater psychological and functional impairment than having either disorder alone. This is especially true in residential settings where both disorders are more severe than outpatient settings.
The investigators propose a prospective, watch-and-measure (no experimental treatment required) study to determine the impact of OSA and associated physiological parameters on clinical outcomes in patients with pulmonary hypertension. The prevalence, phenotypes, and predictors of OSA in the setting of pulmonary hypertension will also be investigated.
The sponsor posted status “Recruiting” on ClinicalTrials.gov at last ingest. Sites can pause independently. Confirm with the official record and the listed contact.
What phase is NCT06792045?
Not a traditional drug phase. Phase labels are FDA/ICH categories applied to the registry Phase field. They are not a finding that this study succeeded.
Can PlainTrials tell me if I qualify for NCT06792045?
No. The inclusion and exclusion lists on this page are readable extracts of the public eligibility block. Only the study team can screen you.